PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.\', \'Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.\', \'Faculty of Medicine, University of Porto, Porto, Portugal.\', \'Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal.\', \'Departamento de Patologia Clínica, Centro Hospitalar Universitário do Porto, Porto, Portugal.\', \'Departamento de Patologia Clínica, Centro Hospitalar Vila Nova de Gaia/Espinho, Gaia, Portugal.\', \'Departamento de Doenças Infeciosas, Centro Hospitalar Vila Nova de Gaia/Espinho, Gaia, Portugal; and.\', \'Departmento de Doenças Infeciosas, Centro Hospitalar Universitário do Porto, Porto, Portugal.\', \'Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal; salomep@ipatimup.pt.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4049/jimmunol.2100131
?:doi
?:hasPublicationType
?:journal
  • Journal of immunology (Baltimore, Md. : 1950)
is ?:pmid of
?:pmid
?:pmid
  • 34417260
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all